Autoimmune Diseases  >>  Humalog pen (insulin lispro)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Humalog pen (insulin lispro) / Eli Lilly
IOPA, NCT00420095: A Study for Patients With Diabetes Mellitus

Completed
4
117
RoW
Human insulin 30/70, Insulin lispro low mix, LM, Low Mix, Humalog
Eli Lilly and Company
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
01/08
01/08
NCT00356421 / 2004-001557-29: A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

Terminated
4
58
US, Europe
Inhaled Human Insulin (Exubera®), Insulin lispro (Humalog)
Pfizer
Diabetes Mellitus, Type 1
06/08
06/08
NCT00985712 / 2008-007769-21: A Study on the Effect of 2 Pen Devices on HbA1c

Completed
4
263
Europe
Insulin Lispro, Humalog, LY275585, Huminsulin Regular, Huminsulin Normal, LY041001, HumaPen Memoir, HumaPen Luxura
Eli Lilly and Company
Diabetes Mellitus, Type 1
07/11
07/11
NCT01526733: Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Completed
4
25
US
Sham Injection, Recombinant human hyaluronidase PH20, rHuPH20, PH20, Hylenex, Insulin aspart, Novolog, Aspart, Insulin lispro, Humalog, Lispro
Halozyme Therapeutics
Type 1 Diabetes Mellitus
08/12
09/13
CONSISTENT 1, NCT01848990: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Completed
4
456
US
Commercial Hylenex® recombinant (hyaluronidase human injection), Formulation 1, Hylenex, Recombinant human hyaluronidase (rHuPH20), Precommercial Hylenex recombinant (hyaluronidase human injection), Formulation 2, rHuPH20, Insulin lispro, Humalog, Lispro, Insulin aspart, Novolog, Aspart, Insulin glulisine, Apidra, Glulisine
Halozyme Therapeutics
Type 1 Diabetes Mellitus
02/14
09/14
NCT01269047: Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Completed
4
37
US
Pramlintide, Symlin, Exenatide, Byetta, Type 1 diabetes, Insulin, Novolog, Humalog, Levemir, Lantus
Albert Einstein College of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes
08/16
12/16

Download Options